RecruitMe Clinical Trial
| Sponsor: | National Institute on Aging |
| Enrolling: | Male and Female Patients |
| Study Length: | 12 Weeks |
| Clinic Visits: | 6 |
| Minimum Age: | 60 years old |
| IRB Number: | 7540 |
| U.S. Government ID: | NCT03321006 |
| Contact: | Marika Chrisanthopoulos: 646-774-8677 / marika.chrisanthopoulos@nyspi.columbia.edu |
In this research study, you will be fitted with hearing aids that may be fully tuned to improve your hearing (full dose) or may be only partially tuned and not likely to substantially improve your hearing (low dose). You will receive a free hearing aid that will be at full dose at the end of the 12 week study. You will also receive treatment for depression with an FDA approved medication called escitalopram (Lexapro) or duloxetine (Cymbalta). Escitalopram is a Selective Serotonin Reuptake Inhibitor (SSRI) medication, and duloxetine is a Selective Serotonin-Norepinephrine Reuptake Inhibitor (SSNRI) that both appear to help with symptoms of depression. The purpose of this study is to determine whether treating hearing loss is helpful for depression over and above the known effects of antidepressants.
